Eating Disorders and Diabetes: Introduction and Overview
- Patricia Colton, MD, FRCPC,
- Gary Rodin, MD, FRCPC,
- Richard Bergenstal, MD and
- Christopher Parkin, MS
Abstract
In Brief
Eating disorders are more common in individuals with type 1 diabetes than in the general population. Although limited research has been conducted in this area, existing evidence shows that these conditions significantly affect the physical and emotional health of individuals with diabetes and are associated with impaired metabolic control and a high risk of medical complications, including higher mortality rates. New nomenclature was recommended at an international focus group held in Minneapolis, Minn., in September 2008. Composed of individuals with interest and expertise in eating disorders among individuals with diabetes, the group recommended that the term ED-DMT1 be used to designate those with an eating disorder and type 1 diabetes and ED-DMT2 be used for those with an eating disorder and type 2 diabetes. This article provides an overview of clinical features, consequences, and pathways of risk associated with ED-DMT1.
Footnotes
-
Patricia Colton, MD, FRCPC, is a staff psychiatrist in the Eating Disorder Program at Toronto General Hospital, in Toronto, Ontario, Canada. Gary Rodin, MD, FRCPC, is a professor of psychiatry at the University of Toronto and head of the Behavioral Sciences and Health Research Division at the Toronto General Research Institute in Toronto, Ontario, Canada. Richard Bergenstal, MD, is an endocrinologist and executive director at the International Diabetes Center at Park Nicollet in Minneapolis, Minn. Christopher Parkin, MS, is president of CGParkin Communications, Inc., in Carmel, Ind.
- American Diabetes Association(R) Inc., 2009
